Cognitive status does not predict motor gain from post stroke constraint-induced movement therapy

NeuroRehabilitation

Volumn 34, Issue 1, 2014, Pages 201-207

  Boe, Ellen Wichard ^a   Pedersen, Anders Degn ^b   Pedersen, Asger Roer ^a   Nielsen, Jørgen Feldbæk ^a   Blicher, Jakob Udby ^a,c  

^a Hammel Neurorehabilitation and Research Centre   (Denmark)

^b Vejlefjord Centre of Rehabilitation   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

cognition; Constraint induced movement therapy; neuropsychological assessment; rehabilitation; stroke; upper extremity

Indexed keywords

COGNITION; CONSTRAINT-INDUCED MOVEMENT THERAPY; NEUROPSYCHOLOGICAL ASSESSMENT; REHABILITATION; STROKE; UPPER EXTREMITY;

ADULT; AGED; COGNITION; EMOTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOVEMENT; PHYSICAL THERAPY MODALITIES; STROKE;

EID: 84894146289     PISSN: 10538135     EISSN: 18786448     Source Type: Journal    
DOI: 10.3233/NRE-131011     Document Type: Article

References (29)

1. Culbertson, W. C., & Zillmer, E. A. (2005). The Tower of London-Drexel University (TOL DXTM). (2nd ed.) NY: Multi-Health Systems Inc.
2. Derogatis, L. R., Lipman, R. S., & Covi, L. (1973). SCL-90: An outpatient psychiatric rating scale-preliminary report. Psy-chopharmacol Bull, 9, 13-28.
3. Dobkin, B. H. (2007). Confounders in rehabilitation trials of task-oriented training: Lessons from the designs of the EXCITE and SCILT multicenter trials. Neurorehabil Neural Repair, 21, 3-13.
4. Fink, P., Orbol, E., Hansen, M. S., Sondergaard, L., & De, J. P. (2004). Detecting mental disorders in general hospitals by the SCL-8 scale. J Psychosom Res, 56, 371-375.
5. Fritz, S. L., Light, K. E., Clifford, S. N., Patterson, T. S., Behrman, A. L., & Davis, S. B. (2006). Descriptive characteristics as potential predictors of outcomes following constraint-induced movement therapy for people after stroke. Phys Ther, 86, 825-832.
6. Fritz, S. L., Light, K. E., Patterson, T. S., Behrman, A. L., & Davis, S. B. (2005). Active finger extension predicts outcomes after constraint-induced movement therapy for individuals with hemi-paresis after stroke. Stroke, 36, 1172-1177.
7. Kaplan, E. F., Goodglass, H., & Weintraub, S. (1983). The Boston Naming Test. (2nd ed.) Philadelphia: Lea & Febiger.
8. Kessels, R. P., Nys, G. M., Brands, A. M., van den Berg, E., & Van Zandvoort, M. J. (2006). The modified Location Learning Test: Norms for the assessment of spatial memory function in neu-ropsychological patients. Arch Clin Neuropsychol, 21, 841-846.
9. Lezak, M. D. (1995). Neuropsychological Assessment Third Edition. New York: Oxford University Press.
10. Lin, K. C., Huang, Y. H., Hsieh, Y. W., & Wu, C. Y. (2009). Potential predictors of motor and functional outcomes after distributed constraint-induced therapy for patients with stroke. Neurorehabil. Neural Repair, 23, 336-342.
11. Lincoln, N. B., Brinkmann, N., Cunningham, S., Dejaeger, E., De, W. W., Jenni, W., et al. (2013). Anxiety and depression after stroke: A 5 year follow-up. Disabil Rehabil, 35, 140-145.
12. Mark, V. W., & Taub, E. (2004). Constraint-induced movement therapy for chronic stroke hemiparesis and other disabilities. Restor Neurol Neurosci, 22, 317-336.
13. Mark, V. W., Woods, A. J., Mennemeier, M., Abbas, S., & Taub, E. (2006). Cognitive assessment for CI therapy in the outpatient clinic. NeuroRehabilitation, 21, 139-146.
14. Morris, D. M., Shaw, S. E., Mark, V. W., Uswatte, G., Barman, J., & Taub, E. (2006). The influence of neuropsychological characteristics on the use of CI therapy with persons with traumatic brain injury. NeuroRehabilitation, 21, 131-137.
15. Nielsen, H., Knudsen, L., & Daugbjerg, O.(1989). Normative data for eight neuropsychological tests based on a Danish sample. Scand J Psychol, 30, 37-45.
16. Reitan, R. M. (1958). Validity of the trail making test as an indicator of organic brain damage. Perceptual and Motor Skills, 8, 271-276.
17. ®. (9.1.3 ed.) Cary, NC: SAS Institute Inc.
18. Strauss, E., Sherman, E., & Spreen, O. (2006). A compendium of neuropsychological tests. (3rd ed.) New York: Oxford University Press.
19. Taub, E. (1980). Somatosensory deafferentation research with monkeys: Implications for rehabilitation medicine. In: L.P. Ince (Eds.), Behavioral Psychology in Rehabilitation Medicine: Clinical applications (pp. 371-401). Baltimore: Williams and Wilkins.
20. Taub, E., Crago, J. E., Burgio, L. D., Groomes, T. E., Cook, E. W., III, DeLuca, S. C., et al. (1994).An operant approachto rehabilitation medicine: Overcoming learned nonuse by shaping. J Exp Anal Behav, 61, 281-293.
21. Taub, E., Miller, N. E., Novack, T. A., Cook, E. W., III, Fleming, W. C., Nepomuceno, C. S., et al. (1993). Technique to improve chronic motor deficit after stroke. Arch Phys Med Rehabil, 74, 347-354.
22. Taub, E., Uswatte, G., Bowman, M. H., Mark, V. W., Delgado, A., Bryson, C., et al. (2013). Constraint-induced movement therapy combined with conventional neurorehabilitation techniques in chronic stroke patients with plegic hands: A case series. Arch Phys Med Rehabil, 94, 86-94.
23. Tulsky, D., Zhu, J., & Ledbetter, M. F. (2002). WAIS-III WMS-III Technical Manual. The Psychological Corporation.
24. Viana, R., & Teasell, R. (2012). Barriers to the implementation of constraint-induced movement therapy into practice. Top Stroke Rehabil, 19, 104-114.
25. Wechsler, D. (1997). Wechsler Adult Intelligence Scale. (3rd ed.) San Antonio: Psychological Corporation.
26. Wechsler, D. (1997). Wechsler Memory Scale. (3rd ed.) San Antonio: The Psychological Corporation.
27. Wilson, B., Cockburn, J., & Halligan, P. (1987). Behavioural inattention test. Suffolk: Thames Valley Test Company.
28. Wolf, S. L., Catlin, P. A., Ellis, M., Archer, A. L., Morgan, B., & Piacentino, A. (2001). Assessing Wolf motor function test as outcome measure for research in patients after stroke. Stroke, 32, 1635-1639.
29. Wolf, S. L., Winstein, C.J., Miller, J.P., Taub, E., Uswatte, G., Morris, D., et al. (2006). Effect of constraint-induced movement therapy on upper extremity function 3 to 9 months after stroke: The EXCITE randomized clinical trial. JAMA, 296, 2095-2104.